ISLAMABAD: Pakistani Prime Minister Shehbaz Sharif said on Thursday, National Diabetes Day, his government was launching a new program for the control and prevention of diabetes in a country where over 33 million people had the chronic disease.
According to a new analysis in The Lancet journal released this week, the percentage of adults suffering from diabetes across the world has doubled over the past three decades, with the biggest rises coming in developing countries.
The serious health condition affected around 14 percent of all adults worldwide in 2022, compared to seven percent in 1990, the Lancet study said. Taking into account the growing global population, the team of researchers estimated that more than 800 million people are now diabetic, compared to less than 200 million in 1990.
“At the Federal level, we will be launching the ‘Prime Minister’s Program for Prevention and Control of Diabetes Mellitus’ under the Ministry of National Health Services, Regulations & Coordination,” Sharif said in a statement.
“Objective of this program is controlling the disease in federal areas and improving capacities in all provinces for providing universal health coverage, diagnosis, and treatment for diabetic patients, along with raising awareness and behavioral change.”
With 33 million of its citizens having diabetes, Pakistan is on the list of countries with the largest diabetic populations. An additional 11 million adults in Pakistan have impaired glucose tolerance, while approximately 8 to 9 million with diabetes remain undiagnosed.
“The major risk factors leading to diabetes in Pakistan are environmental and geographical reasons in addition to genetic variants, dietary, as well as inactive lifestyle,” Sharif said.
“The Government of Pakistan is fully committed in controlling this escalation and delivering wellbeing to diabetic population.”
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood glucose.
Type 1 diabetes affects patients from a young age and is more difficult to treat because it is caused by an insulin deficiency. Type 2 mainly affects middle-aged or older people who lose their sensitivity to insulin.